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INTRODUCTION: Multimodal treatment incorporating surgical resection and the use of 
chemotherapeutic drugs is commonly used in the management of esophageal cancer. 
However, resistance to chemotherapy drugs may contribute to poor treatment outcome 
and cancer recurrence. Increasing evidence suggests that miRNAs regulate the sensitivity 
of cancer to chemotherapeutic drugs. 5-Fluorouracil (5-FU) is an antimetabolite agent 
commonly used to treat esophageal cancer. MATERIAL AND METHOD: We have 
established 5-FU-resistant (FR) esophageal squamous cell carcinoma (ESCC) cell lines as 
cell models to study the mechanisms of chemoresistance. These FR cell lines overexpress 
thymidylate synthase, which is generally regarded as a marker of 5-FU resistance. 
RESULTS AND DISCUSSION: We found that miR-338-5p was downregulated whereas 
Id1, which was one of its predicted targets according to target prediction algorithms, was 
upregulated in the FR cells. Luciferase reporter assay confirmed that miR-338-5p could 
directly bind to the 3’ untranslated region (UTR) of Id1. Overexpression of miR-338-5p 
downregulated endogenous Id1 protein level in esophageal cancer cell lines, whereas 
knockdown of miR-338-5p produced the opposite effect. The inhibitory effect of miR- 
338-5p on Id1 expression was further confirmed using Tet-on ESCC cell lines inducible 
for miR-338-5p expression. Flow cytometry and Western blotting were performed to 
study the effects of miR-338-5p overexpression and inhibition on 5-FU-induced 
apoptosis. The results showed that miR-338-5p overexpression restored sensitivity of the 
FR cells to 5-FU treatment both in vitro and in vivo, and that knockdown of miR-338-5p 
induced 5-FU resistance in chemosensitive esophageal cells. These effects were 
abolished by expression of Id1 and shId1, respectively. CONCLUSION: Taken together, 
our data suggest that miR-338-5p can modulate the chemosensitivity of ESCC cells by 
regulating Id1. Since previous studies showed that Id1 is frequently upregulated in ESCC 
and is a marker for unfavorable prognosis, miR- 338-5p and its suppressive effect on Id1 
may be exploited to develop novel therapies for treatment of esophageal cancer. 
